Call Now

Human KIR2DL4 / CD158D Protein

CD158D,G9P,KIR,KIR-103AS,KIR103,KIR103AS,KIR2DL4

Catalog Number P13052-HCCS
Organism Species Human
Host CHO Stable Cells
Synonyms CD158D,G9P,KIR,KIR-103AS,KIR103,KIR103AS,KIR2DL4
Molecular Weight The recombinant human KIR2DL4 consists of 228 amino acids and predicts a molecular mass of 25.1 KDa. It migrates as an approximately 33-37 KDa band in SDS-PAGE under reducing conditions.
predicted N Trp 24
SDS-PAGE
Purity > 85 % as determined by SDS-PAGE
Protein Construction A DNA sequence encoding the human KIR2DL4 (ADY38409.1)(Met1-His242) was expressed with six amino acids (LEVLFQ) at the C-terminus was expressed and purified.
Bio-activity
Research Area Cancer |Signal transduction |ITIM/ITAM Immunoreceptors and Related Molecules
Formulation Lyophilized from sterile PBS, pH 7.4.
1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
Background KIR2DL4, also known as CD158d, is a member of the killer cell Ig-like receptor (KIR) family. KIRs are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous. KIR2DL4 is expressed in all NK cells and some T cells. KIR2DL4 activates the cytotoxicity of NK cells, despite the presence of an immunoreceptor tyrosine-based inhibition motif (ITIM) in its cytoplasmic tail. The ITIM was not necessary for activation of lysis by KIR2DL4. The activation signal of KIR2DL4 was sensitive to inhibition by another ITIM-containing receptor. The activation-deficient mutant of KIR2DL4 inhibited the signal delivered by the activating receptor CD16.
Reference
  • Selvakumar A. et al., 1997, Tissue Antigens. 48 (4 Pt 1): 285-94.
  • Selvakumar A. et al., 1997, Immunol Rev. 155: 183-96.
  • Selvakumar A. et al., 1997, Tissue Antigens. 49 (6): 564-73.